Atlas Trials

Phase 1 Safety Study of ALRN-5281 in Healthy Subjects

Clinical trial NCT01775358 · COMPLETED

Trial details

NCT number
NCT01775358
Sponsor
Aileron Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Growth Hormone Deficiency
Start date
2013-01-01
Primary completion
2013-05-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.